chrisvoncsefalvay/vaers-outcomes huggingface dataset:
localized reaction was red and warm to the touch; localized reaction was red and warm to the touch; localized reaction was red and warm to the touch; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE WARMTH (localized reaction was red and warm to the touch), the first episode of INJECTION SITE ERYTHEMA (localized reaction was red and warm to the touch) and the second episode of INJECTION SITE ERYTHEMA (localized reaction was red and warm to the touch) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Jan-2021, the patient experienced INJECTION SITE WARMTH (localized reaction was red and warm to the touch) and the first episode of INJECTION SITE ERYTHEMA (localized reaction was red and warm to the touch). On 19-Jan-2021, the patient experienced the second episode of INJECTION SITE ERYTHEMA (localized reaction was red and warm to the touch). On 16-Jan-2021, INJECTION SITE WARMTH (localized reaction was red and warm to the touch) had resolved. At the time of the report, last episode of INJECTION SITE ERYTHEMA (localized reaction was red and warm to the touch) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided (patient reported she did not try anything to treat it).  No concomitant medication was provided.
headache; Mild body aches; This is a spontaneous report from a contactable nurse (patient). A 46-year-old female patient received 1st dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via intramuscular on 13Jan2021 at 09:00 at single dose on right arm for covid-19 immunisation. Medical history included blood cholesterol increased. Concomitant medication included naproxen, simvastatin and ASA, all from unknown date for unknown indication. The patient previously took bupropion hydrochloride (WELLBUTRIN) and experienced allergy. The patient experienced mild body aches and headache beginning 12 hours after dose on 13Jan2021 with outcome resolved. No treatment received.  Information on the Lot/Batch number has been requested. .
I am the epidemiologist reporting on behalf of patient. The patient is fully vaccinated and the second dose of Pfizer. Date of second vaccine was listed as 05/08. Case began new medication, began vommiting 6/25. Got tested for COVID-19, tested +,. The patient was is in end stage liver disease awaiting a transplant and was tested as part of routine testing for weekly paracentesis. The patient's wife reports that he began three new medications on 6/24 and began vomiting that evening. Patient was admitted after testing positive because the test caused him to miss his paracentesis procedure and has no other symptoms. Patient is listed as having died from COVID-19, end stage liver failure, and liver cirrhosis.
Four days after the 2nd dose, my blood pressure became elevated to 140/80. I went to the Emergency Room where the following tests were performed: BMP, CBC with Differential, Flu/RSV//Covid PCR, Troponin Ohr (initial), Urinalysis reflex Microscopy/Culture, CT  HEAD BRAIN WITHOUT CONTRAST. Findings: No evidence of intra- or esttraaxial hemorrhage, mass effect, midline shift, hydrocephalus or acute transcortial infarct, No acute intracranial pathology.  Cardiac silhouette and pulmonary vesselas are within normal range. No infiltrate, pleural effusion or pneumothorax. Impression: No acute disease. There were no other event occurences in my life to generate anxiety. Also General muscle
Initial report received from another company (no reference number provided) in the United States on 07 August 2007. The other company received the report from a health care professional. A 14-year-old female patient with a medical history of depression and sulfa allergy had received typhoid vaccine in March 2007. The trade name, manufacturer, lot number, route and site of administration were not reported. An unspecified amount of time following vaccination, the patient developed a severe allergic reaction. The patient was taken to the hospital and treated in the emergency room for difficulty breathing and a "throat that closed off". The patient was given Benadryl in the emergency room and was sent home on two days of prednisone. The event was considered by the reporter to be life threatening. The patient recovered from the event. The product was not reintroduced to the patient after the event.
1. Severe rheumatoid arthritis flare that required additional prednisone dosages. Started 10/01/21 and resolved around 10/15/21.  2. Mild rash (looked like welts) on neck, started 10/01/21 and resolved around 10/07/21. Used topical OTC  Benadryl cream 3. Moderate malaise, started 10/01/21 and resolved around 10/07/21, No treatment, just rested 4. Upper respiratory infection symptoms, started 10/02/21 and resolved around 10/07/21. Used OTC cold and allergy medication
Patient called and said that the injection site is swollen big like a fist of hand, redness, itching. I counsel pt to take BENADRYL, Ibu and call MD if symptoms is not improved.
Given the wrong vaccine due to administrative oversight. Shingles vaccine was administered instead of Chicken pox vaccine. No symptoms so far.
PATIENT FAINTED AFTER ADMINISTRATION OF MODERNA COVID VACCINE. PATIENT HAD REPORTED HISTORY OF FAINTING ON PATIENT CONSENT FORM.
Arm very swollen, red and hot to the touch. Patient saw doctor on 9/4/13 and has been applying ice.
When the medical assistant was administering the flu shot in the patient's left arm, the patient jerked away and slid off the table, resulting in an incomplete dosage. The vaccine needle bent, and the medical assistant is unsure of the amount that was injected into the patient intramuscularly. The patient's primary care provider informed the patient's parents that it is safe to administer the full dose of the flu vaccine into the right arm on the same day. The mother of the patient did not want to go forward with a full dose in the patient's right arm today, and the patient's parents rescheduled for 1/4/2023 to receive the full dose of the flu vaccine at that time. The medical assistant marked the vaccine as "Not Given" per supervisor.
Burning/tingling sensation on skin around mouth; Burning/tingling sensation on skinaround mouth; Tingling sensation in legs ankles and feet; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 29Mar2021 at 12:00 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Medical history included allergy to maple. Concomitant medications included cefalexin (CEPHALEXIN) at a dose of 500 mg twice daily from an unknown date for an unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 29Mar2021 at 20:15, the patient experienced tingling sensation in legs, ankles and feet and burning/tingling sensation on skin around mouth. The adverse events did not result in a visit to the doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events tingling sensation in legs, ankles and feet and burning/tingling sensation on skin around mouth. The clinical outcomes of the events tingling sensation in legs, ankles and feet and burning/tingling sensation on skin around mouth were unknown at the time of the report.   No follow-up attempts are needed. No further information is expected.
About 2.5 days after receiving the shot I woke up with the worst headache of my life. Crazy chills and felt extremely tired.  That went on for about 4 days.  Then had nausea and diarrhea and a stuffed up nose towards the end.  My symptoms lasted  a total of 9 days.
immediate cognitive impairment; severe numbness/tingling/buzzing sensation all over my body,; severe numbness/tingling/buzzing sensation all over my body; severe numbness/tingling/buzzing sensation all over my body; extreme fatigue; insomnia; nausea; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the right arm on 25Mar2021 at 09:30 (at the age of 42-year-old) as dose number unknown, single for COVID-19 immunization. Medical history included interstitial cystitis, low back pain/disc herniation and COVID-19. Concomitant medications included pantoprazole (MANUFACTURER UNKNOWN) and escitalopram oxalate (LEXAPRO); both from an unknown date for an unknown indication. The patient had no known allergies to medications, food or other products. Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 25Mar2021 at 09:45 the patient felt immediate cognitive impairment, almost was worried to drive home. On an unknown date in Mar2021, within 3-4 days of vaccination, the patient experienced severe numbness/tingling/buzzing sensation all over the body, extreme fatigue, insomnia, nausea, and severe cognitive impairment. The events resulted in doctor or other healthcare professional office/clinic visit. The patient did not receive any treatment for the events. The clinical outcome of the event cognitive impairment, numbness, tingling, buzzing sensation all over the body, extreme fatigue, insomnia and nausea were not recovered.   No follow-up attempts are needed. No further information is expected.  Amendment: This follow-up report is being submitted to amend previously reported information: Relevant medical history added.
The father reports after receiving vaccinations his son developed vomiting, injection site redness and experienced irritability. The father indicated that all sx resolved within 2 or 3 days.
pt recvd vax; w/in 5 hrs of vax devel fever of 104; tx w/ acetaminophen & fever dec to 102;2nov95 fever persisted but dec 10 101-102; next day fever resolved
Prodrome 1 week ago with a few scattered lesions. Multiple lesions today with varied papules at different stages of healing. P. course and rash discussed, RTC prn.
Pt was vaccinated with Pfizer booster dose on 10/26 but pt only finished primary series on 5/17/21 (~5months prior).  At the time of vaccination. Pt experienced headaches and body aches on 10/27.  ON 10/28, pt had only that was relieved by Tylenol.  Pt went about daily activities including going to school w/ no issues.
Vaccine was given on 8/10/23  BUD date of vaccine was 08/01/2023
Arm tenderness for 3 days after, which I know is common but then 1 week later raised on the surface below injection site with redness, and itchiness.
PAIN UNDER ARMS; CHILLS; MUSCLE ACHES; This spontaneous report received from a consumer concerned a male of unspecified age. The patient's height, and weight were not reported. The patient's concurrent conditions included diabetes.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805018) dose was not reported, administered on 19-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 19-MAR-2021, the subject experienced pain under arms. On 19-MAR-2021, the subject experienced chills. On 19-MAR-2021, the subject experienced muscle aches. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from chills, pain under arms, and muscle aches. This report was non-serious.
Patient reported paralysis in the lower half of his body, numbness, breathing difficulties, swallowing difficulties, an inability to urinate, an inability to produce bowel movements and a blood pressure of 234/168. He reported onset of these symptoms as the evening of 10/19/09. The patient was admitted to the ICU for critical breathing conditions within eight days after the vaccination. As of 11/17/09 he reports still having tingling, numbness, and an inability to walk. He reported a diagnosis of GUILLAIN-BARRE Syndrome by the Neuroscience Team. We have been unable to reach this person.
About two weeks after I received the booster vaccine my prostate became even more enlarged than it was. I talked to my doctor in February and then went to see my doctor in March for testing. By early June I was admitted to the hospital where it was decided to add medication to my normal medication routine. I am feeling better.
Patient initially presented with nausea vomiting dehydration was found to have COVID-19 disease however was not severe and did not require oxygen supplementation.  Patient was given IV fluids antiemetics with resolution of lactic acidosis and sepsis.  The following day the patient's nausea and vomiting had resolved she was able to tolerate a regular breakfast without difficulty.  Patient also had significant improvement of cough and shortness of breath.  Patient stated that she felt well enough to go home.  Patient was discharged with oral medications for cough and nausea control as needed.  Patient had 2 days total of remdesivir.  Patient was not given dexamethasone as inpatient or outpatient because she did not develop acute hypoxemic respiratory failure.  Patient was discharged home and follow-up with primary care to ensure continued resolution of infectious signs and symptoms and optimization of other medical issues.
significant reaction to the first shot; This case was reported by a pharmacist via call center representative and described the occurrence of adverse reaction in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced adverse reaction. On an unknown date, the outcome of the adverse reaction was recovered/resolved.   It was unknown if the reporter considered the adverse reaction to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient received Shingrix and had such a significant reaction. The reporter consented to follow up. Outbound call made to obtain more information no answer.  The reporter left voicemail for callback purposes. For tolerances of 2nd dose, refer case US2020AMR152226, reported by same reporter for the same patient.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020AMR152226:same reporter
A report has been received from a health professional concerning a 9 year old, female subject, who had been receiving nasal FLUMIST QUADRIVALENT. FLUMIST QUADRIVALENT started on 10-Jan-2014. The patient experienced cough (Preferred Term: cough) and Fever (Preferred Term: Pyrexia) which started on 14-Jan-2014. At the time of reporting, the event of cough and fever was ongoing. The report was considered to be non-serious.
dizziness; he had "a hard a time walking"; develop a sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (develop a sore arm), DIZZINESS (dizziness) and GAIT DISTURBANCE (he had "a hard a time walking") in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012o20a) for COVID-19 vaccination.     No medical history was provided by reporter.  Concomitant products included MECLIZINE HCL for an unknown indication.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Jan-2021, the patient experienced PAIN IN EXTREMITY (develop a sore arm) and GAIT DISTURBANCE (he had "a hard a time walking"). On an unknown date, the patient experienced DIZZINESS (dizziness). At the time of the report, PAIN IN EXTREMITY (develop a sore arm), DIZZINESS (dizziness) and GAIT DISTURBANCE (he had "a hard a time walking") was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications also included Blood pressure medication. Treatment details was not provided by reporter.
This spontaneous report was received from a certified medical assistant regarding 9 patients of unknown demographics. There was no information about concurrent condition and historical medication. On an unknown date the patients were vaccinated with improperly stored PROQUAD, lot no. M022399/expiration date-01-NOV-2017 (incorrect product storage). No adverse event was reported. No concomitant medication was reported. The outcome of the event was unknown. No PQC (product quality complaint) was involved. This is one of several reports received from the same reporter. Additional information is not expected as reporter does not wants to get contacted.
I haven't had a period since I had my second shot. I was due to start that weekend and never did. It's been 5 months. Asked a few of my doctors, none seemed concerned.
Next day after vaccines developed copious diarrhea. Had fever 101 once or twice. Worse the night of vaccines.
physician reported that 200 pt over the past 3 months have exp fever, crying, and soreness following vax. additional info recv from physician; he stated that he was unaware of any adverse exp in any of his pt who recv vax
The staff thought the punctured vial expiration is 24 hours and not 12 hours after 1st puncture/Patients administered dose beyond 12 hours after first vial puncture; putting the vial back in the refrigerator at the end of the day; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (The staff thought the punctured vial expiration is 24 hours and not 12 hours after 1st puncture/Patients administered dose beyond 12 hours after first vial puncture) and PRODUCT STORAGE ERROR (putting the vial back in the refrigerator at the end of the day) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046C21A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (The staff thought the punctured vial expiration is 24 hours and not 12 hours after 1st puncture/Patients administered dose beyond 12 hours after first vial puncture) and PRODUCT STORAGE ERROR (putting the vial back in the refrigerator at the end of the day). At the time of the report, EXPIRED PRODUCT ADMINISTERED (The staff thought the punctured vial expiration is 24 hours and not 12 hours after 1st puncture/Patients administered dose beyond 12 hours after first vial puncture) and PRODUCT STORAGE ERROR (putting the vial back in the refrigerator at the end of the day) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 24-Sep-2021: Follow up case: The lot/batch numbers provided. On 24-Sep-2021: Significant follow-up-Lot details updated.
Approximately 5 days after vaccine, patient started itching on left shoulder and collar bone area. Rash proceeded to spread covering most areas of body except face. Rash has chicken pox like appearance. Patient saw physician & was prescribed Acyclovir as well as topical CALAMINE lotion.
PT DID NOT WAIT FULL 15 MINUTES WAS TOLD TO WAIT AFTER COVID -19 VACCINE GIVEN. UPON LEAVING PHARMACY AFTER APROXIMATELY 5 MINUTES FELT FAINT AND FATHER CALLED PHARMACIST FOR HELP. FATHER WAS ASKED IF WANTS 911 CALLED AND SAID NO.  PT WAS TOLD TO LAY ON THE FLOOR ON HER SIDE AND WAS GIVEN WATER AND COLD COMPRESSES BY THE PHARMACIST. WAS ALERT AND COHERENT THE WHOLE TIME. LAYED ON THE FLOOR FOR ABOUT 10 MINUTES THEN WHEN STARTED TO FEAL BETTER PHARMACIST HAD PATIENT SIT UP FOR ANOTHER 10 MINUTES. PATIENT SAID WAS FEELING BETTER AND WANTED TO TRY TO STAND UP. THEN STILL UNDER PHARMACIST OBSERVATION REMAINED STANDING FOR APROXIMETLY 10 MORE MINUTES. WHEN PATIENT FELT FULLY BACK TO HERSELF WALKED OUR OF PHARMACY WITH DAD. TECHNICIAN FOLLOWED THEM OUT TO MAKE SURE EVERYTHING WAS OK AND THEY LEFT. PATIENT DID NOT FEAL NAUSEAS AND WAS AWAKE THE WHOLE TIME. FATHER KEPT URGING PATIENT TO GO BUT PHARMACIST INSISTED ON THEM WAITING AS LONG AS POSIBLE TO MAKE SURE PATIENT WAS FINE.
Administered vaccine past 75 days of storage in the fridge to 25 days past BUD. I'm calling all 55 patients to let them know their options.
pt recvd vax; exp fever, lasting x 4 days p/ vax; t 103 R when seen in ofc;
Injection site swollen to the size of a small to medium egg, fever, swollen glands under the armpit of the injection arm, can't lift the arm up too high.
This spontaneous report as received from a physician via a field representative refers to a 6 week old female patient. Drug reactions and allergies were reported as none. On 28-OCT-2014 the patient was vaccinated with ROTATEQ dose 1, exactly half a dose, oral. On 28-OCT-2014, the patient received half a dose of ROTATEQ and vomited and was unable to take the remainder of the dose.  No treatment was given to the patient. No lab tests were performed. The outcome of vomited and received half a dose is unknown. The reporter considered received half a dose to be not related to ROTATEQ. Additional information has been requested.
Info has been received from a woman in a medical office concerning a pt who was vaccinated with a dose of pneumococcal vaccine 23 polyvalent (lot #644106/0819M) intramuscularly in the deltoid. Subsequently, the pt experienced nausea and vomiting and developed a rash. He also developed redness, swelling and soreness at the injection site and down the arm. On 12/18/2002, it was reported that the pt's symptoms had subsided by the next day and that no treatment, testing or work-up was necessary. Additional info is not expected.
on Sunday, three days after reeving vaccine I felt what I best describe a a strange sensation on the whole left side of my face- about an hour later I felt a bump on the top of my head- if felt like an enflamed pimple and was vey sensitive---it disappeared after a few hours and then I had a bump on my earlobe that also felt like an enflamed pimple- very strange... when I woke up on Monday all of this was gone and no further effects